Introduction Although there have been reports of chemotherapy-induced nausea and
vomiting (CINV) beyond 120 h, its overall prevalence has not been systematically examined …

PURPOSE Anorexia occurs in 30%-80% of patients with advanced malignancies, which
may be worsened with chemotherapy. This trial assessed the efficacy of olanzapine in …

Chemotherapy-induced nausea and vomiting (CINV) is a common side effect of most
chemotherapy agents. Suboptimal management of CINV impacts quality of life, nutrition …

This clinical practice guideline provides recommendations for preventing acute and delayed
phase chemotherapy‐induced nausea and vomiting (CINV) in pediatric patients. The …

Chemotherapy-induced nausea and vomiting (CINV) remain the most distressing event in
patients receiving highly emetogenic chemotherapy (HEC) and moderately emetogenic …

Tumors of the gastrointestinal tract are one of the highest incidences of morbidity and
mortality in humans. Recently, a growing number of researchers have indicated that nerve …

Chemotherapy-induced nausea and vomiting (CINV) is a serious side effect of
chemotherapy that negatively impacts the quality of life of oncological patients and is …

Objective We aimed to assess the effects of olanzapine in the improvement of body weight
and appetite in patients with cancer or receiving chemotherapy through a systematic review …

Background: In this trial, we evaluated the safety and efficacy of olanzapine in children
receiving highly emetogenic chemotherapy. Materials and Methods: In this study, patients …

Background: In order to improve the complete recovery of nausea and vomiting, we
conducted a study with the aim of preventing acute and delayed nausea and vomiting in …